Patents by Inventor Alessandra Bitto

Alessandra Bitto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ISTRADEFILLIN TO REDUCE ORGAN FIBROSIS
    Publication number: 20240277718
    Abstract: The present invention concerns istradefylline use for the reduction of organ fibrosis.
    Type: Application
    Filed: May 30, 2022
    Publication date: August 22, 2024
    Inventors: Alessandra Bitto, Francesco Squadrito, Domenica Altavilla, Natasha Irrera
  • METHODS OF TREATING MUSCULAR DYSTROPHIES
    Publication number: 20130210753
    Abstract: The invention relates to methods of treating Duchenne muscular dystrophy with flavonoids. The methods may include (a) providing a pharmaceutical composition comprising a therapeutically effective amount of flavonoid, and (b) administering the composition to a human patient, wherein the flavonoid comprises an isoflav-4-one with at least one of the carbons located at positions 8, 7, 6, 5, 2, 2?, 3?, 4?, 5?, or 6? modified by an alcohol group. Alternatively, the flavonoid may comprise (1) a flavan-3-ol with at least one of the carbons located at positions 8, 7, 6, 5, 4, 2?, 3?, 4?, 5?, or 6? modified by an alcohol group, or (2) a Free-B-Ring flavone with at least one of the carbons located at positions 8, 7, 6, 5 or 3 modified by an alcohol group and with at least one of the carbons located at positions 8, 7, 6, 5 or 3 modified by a glycoside group.
    Type: Application
    Filed: June 1, 2012
    Publication date: August 15, 2013
    Applicant: PRIMUS PHARMACEUTICALS INC.
    Inventors: Francesco Squadrito, Alessandra Bitto, Giuseppe Vita, Sonia Messina, Bruce P. Burnett
  • Methods of Treating Muscular Dystrophies
    Publication number: 20100190733
    Abstract: The invention relates to methods of treating Duchenne muscular dystrophy with flavonoids. The methods may include (a) providing a pharmaceutical composition comprising a therapeutically effective amount of flavonoid, and (b) administering the composition to a human patient, wherein the flavonoid comprises an isoflav-4-one with at least one of the carbons located at positions 8, 7, 6, 5, 2, 2?, 3?, 4?, 5?, or 6? modified by an alcohol group. Alternatively, the flavonoid may comprise (1) a flavan-3-ol with at least one of the carbons located at positions 8, 7, 6, 5, 4, 2?, 3?, 4?, 5?, or 6? modified by an alcohol group, or (2) a Free-B-Ring flavone with at least one of the carbons located at positions 8, 7, 6, 5 or 3 modified by an alcohol group and with at least one of the carbons located at positions 8, 7, 6, 5 or 3 modified by a glycoside group.
    Type: Application
    Filed: January 26, 2010
    Publication date: July 29, 2010
    Applicant: Primus Pharmaceuticals, Inc.
    Inventors: Francesco Squadrito, Alessandra Bitto, Giuseppe Vita, Sonia Messina, Bruce P. Burnett